Rapid heart pump upgrade may save lives in shock
NCT ID NCT07655479
First seen Jun 26, 2026 ยท Last updated Jun 26, 2026
Summary
This study tests whether quickly upgrading from a standard heart pump (Impella CP) to a more powerful one (Impella 5.5) within 24 hours after a heart attack improves outcomes for people in cardiogenic shock. The trial will enroll 115 adults aged 18-77 who have had a heart attack and need extra heart support. The goal is to see if this faster escalation reduces the need for strong medications and leads to fewer complications.
What this could mean
Our plain-language read of the trial. This is informational only โ not medical advice or a prediction.
- Active substance
- Impella heart pumps (Impella CP and Impella 5.5)
- What this could lead to
- If successful, this could lead to a faster, more effective way to support the heart during cardiogenic shock, potentially reducing complications and improving survival.
- What could go wrong
- This is a relatively small, early-stage trial (115 people) and the results may not apply to all patients. The procedure itself carries risks like bleeding or infection.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CARDIOGENIC SHOCK DUE TO ACUTE MYOCARDIAL INFARCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital Cologne
RECRUITINGCologne, 50937, Germany
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Heart rate drug may speed recovery from shock after heart attack
- Can a heart Pump's data predict who will recover?
- 800-Patient registry aims to unlock secrets of heart shock survival
- Could less blood pressure medicine save more lives in heart shock?
- Designer cells aim to calm immune system after massive heart attack
- New study aims to unravel deadly shock combo in heart patients